(Q44095020)

English

Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance

scientific article published on 30 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance (English)

1 reference

Europe PubMed Central

29 November 2017

DNA methylation

0 references

author name string

Jui Lan

1

1 reference

Europe PubMed Central

29 November 2017

Hui-Chun Tai

2

1 reference

Europe PubMed Central

29 November 2017

Sung-Wei Lee

3

1 reference

Europe PubMed Central

29 November 2017

Tzu-Ju Chen

4

1 reference

Europe PubMed Central

29 November 2017

Hsuan-Ying Huang

5

1 reference

Europe PubMed Central

29 November 2017

Chien-Feng Li

6

1 reference

Europe PubMed Central

29 November 2017

publication date

30 July 2013

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

35

1 reference

Europe PubMed Central

29 November 2017

1

1 reference

Europe PubMed Central

29 November 2017

161-169

1 reference

Europe PubMed Central

29 November 2017

https://scigraph.springernature.com/pub.10.1007/s13277-013-1020-8

0 references

Epidemiology of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Controversies and challenges in the current management of nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Focus on nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Genetic and epigenetic changes in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Assembly of microarrays for genome-wide measurement of DNA copy number

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Targeting metabolic transformation for cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Regulation of cancer cell metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1020-8

21 January 2018

Advances in nasopharyngeal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23897555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23897555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23897555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-1020-8

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44095020&oldid=2106541141"